This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignee: Syngenta Participations Ag. Active years: 2011-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2018
Title: Enrico Gerardus Albertus Linders: Innovator in Plant Resistance
Introduction
Enrico Gerardus Albertus Linders is a notable inventor based in Enkhuizen, Netherlands. He has made significant contributions to the field of plant resistance, particularly in developing plants that are resistant to clubroot disease. With a total of 6 patents to his name, Linders has established himself as a key figure in agricultural innovation.
Latest Patents
Linders' latest patents focus on creating plants that exhibit monogenic dominant resistance to clubroot disease. This innovation provides improved resistance compared to previously existing resistances in Brassica plants. His inventions also encompass novel plants and their seeds, along with methods for producing these plants and seeds. Additionally, he has developed molecular markers that are useful in marker-assisted breeding and for identifying resistance traits in plants.
Career Highlights
Linders is currently associated with Syngenta Participations AG, a leading company in agricultural science. His work at Syngenta has allowed him to push the boundaries of plant resistance research and contribute to sustainable agricultural practices.
Collaborations
Throughout his career, Linders has collaborated with esteemed colleagues such as Peter Tjeertes and Johannes Maria De Haas. These collaborations have further enhanced his research and development efforts in the field of plant resistance.
Conclusion
Enrico Gerardus Albertus Linders is a prominent inventor whose work in plant resistance has made a significant impact on agriculture. His innovative patents and collaborations continue to advance the field, ensuring better crop resilience against diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
